224 related articles for article (PubMed ID: 26964729)
1. Differential Effects of Oral and Intravenous Lipid Administration on Key Molecules Related to Energy Homeostasis.
Vamvini MT; Hamnvik OP; Sahin-Efe A; Gavrieli A; Dincer F; Farr OM; Mantzoros CS
J Clin Endocrinol Metab; 2016 May; 101(5):1989-97. PubMed ID: 26964729
[TBL] [Abstract][Full Text] [Related]
2. Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.
Lindgren O; Carr RD; Deacon CF; Holst JJ; Pacini G; Mari A; Ahrén B
J Clin Endocrinol Metab; 2011 Aug; 96(8):2519-24. PubMed ID: 21593115
[TBL] [Abstract][Full Text] [Related]
3. Increased Incretin But Not Insulin Response after Oral versus Intravenous Branched Chain Amino Acids.
Gojda J; Straková R; Plíhalová A; Tůma P; Potočková J; Polák J; Anděl M
Ann Nutr Metab; 2017; 70(4):293-302. PubMed ID: 28595189
[TBL] [Abstract][Full Text] [Related]
4. Incretin effect after oral amino acid ingestion in humans.
Lindgren O; Pacini G; Tura A; Holst JJ; Deacon CF; Ahrén B
J Clin Endocrinol Metab; 2015 Mar; 100(3):1172-6. PubMed ID: 25490278
[TBL] [Abstract][Full Text] [Related]
5. Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis.
Edholm T; Degerblad M; Grybäck P; Hilsted L; Holst JJ; Jacobsson H; Efendic S; Schmidt PT; Hellström PM
Neurogastroenterol Motil; 2010 Nov; 22(11):1191-200, e315. PubMed ID: 20584260
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients.
Damjanovic SS; Lalic NM; Pesko PM; Petakov MS; Jotic A; Miljic D; Lalic KS; Lukic L; Djurovic M; Djukic VB
J Clin Endocrinol Metab; 2006 Jul; 91(7):2574-81. PubMed ID: 16621911
[TBL] [Abstract][Full Text] [Related]
7. Assessment of incretins in oral glucose and lipid tolerance tests may be indicative in the diagnosis of metabolic syndrome aggravation.
Kiec-Klimczak M; Malczewska-Malec M; Razny U; Zdzienicka A; Gruca A; Goralska J; Pach D; Gilis-Januszewska A; Dembinska-Kiec A; Hubalewska-Dydejczyk A
J Physiol Pharmacol; 2016 Apr; 67(2):217-26. PubMed ID: 27226181
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin Impairs Prandial Glucose Tolerance and Insulin Secretion in Healthy Humans Despite Increasing GLP-1.
Tong J; Davis HW; Gastaldelli A; D'Alessio D
J Clin Endocrinol Metab; 2016 Jun; 101(6):2405-14. PubMed ID: 27055279
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha.
Freeland KR; Wolever TM
Br J Nutr; 2010 Feb; 103(3):460-6. PubMed ID: 19818198
[TBL] [Abstract][Full Text] [Related]
10. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
11. Differential islet and incretin hormone responses in morning versus afternoon after standardized meal in healthy men.
Lindgren O; Mari A; Deacon CF; Carr RD; Winzell MS; Vikman J; Ahrén B
J Clin Endocrinol Metab; 2009 Aug; 94(8):2887-92. PubMed ID: 19435824
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects.
Haluzíková D; Lacinová Z; Kaválková P; Drápalová J; Křížová J; Bártlová M; Mráz M; Petr T; Vítek L; Kasalický M; Haluzík M
Obesity (Silver Spring); 2013 Jul; 21(7):1335-42. PubMed ID: 23670968
[TBL] [Abstract][Full Text] [Related]
13. GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects.
Fernández-García JC; Murri M; Coin-Aragüez L; Alcaide J; El Bekay R; Tinahones FJ
Clin Endocrinol (Oxf); 2014 May; 80(5):671-6. PubMed ID: 23573808
[TBL] [Abstract][Full Text] [Related]
14. HNF1α defect influences post-prandial lipid regulation.
St-Jean M; Boudreau F; Carpentier AC; Hivert MF
PLoS One; 2017; 12(5):e0177110. PubMed ID: 28493909
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study.
Herder C; Ouwens DM; Carstensen M; Kowall B; Huth C; Meisinger C; Rathmann W; Roden M; Thorand B
Eur J Endocrinol; 2015 Apr; 172(4):423-32. PubMed ID: 25733068
[TBL] [Abstract][Full Text] [Related]
16. Acute hormonal changes following intravenous glucose challenge in lean and obese human subjects.
Haltia LT; Savontaus E; Vahlberg T; Rinne JO; Kaasinen V
Scand J Clin Lab Invest; 2010 Jul; 70(4):275-80. PubMed ID: 20429700
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic Effects of Low-Dose Pioglitazone in Patients with the Metabolic Syndrome without Diabetes Mellitus.
Vu A; Kosmiski LA; Beitelshees AL; Prigeon R; Sidhom MS; Bredbeck B; Predhomme J; Deininger KM; Aquilante CL
Pharmacotherapy; 2016 Mar; 36(3):252-62. PubMed ID: 26822630
[TBL] [Abstract][Full Text] [Related]
18. The effect of pregnane X receptor agonists on postprandial incretin hormone secretion in rats and humans.
Hukkanen J; Rysa J; Makela KA; Herzig KH; Hakkola J; Savolainen MJ
J Physiol Pharmacol; 2015 Dec; 66(6):831-9. PubMed ID: 26769831
[TBL] [Abstract][Full Text] [Related]
19. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
20. On the role of the gut in diabetic hyperglucagonaemia.
Lund A
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
